Themis Bioscience
About:
Themis Bioscience is a start-up biotechnology company.
Website: http://www.themisbio.com/
Top Investors: Innovate UK, Merck, Credit Agricole CIB, Wellington Partners, Ventech
Description:
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.
$150M
$1M to $10M
Vienna, Wien, Austria
2009-09-01
office(AT)themisbio.com
Dr. Erich Tauber
11-50
2020-03-19
Private
© 2025 bioDAO.ai